Drug Use Investigation of Julina Tablets 0.5 mg (Postmenopausal Osteoporosis)
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2015
At a glance
- Drugs Estradiol/levonorgestrel (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions
- Sponsors Bayer
- 02 Jun 2014 Trial status changed to completed as reported by ClinicalTrials.gov.
- 19 Mar 2013 Planned End Date changed from 1 Dec 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov record.
- 23 Jul 2011 New trial record